Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep

S. Lanes, J. S. Stevenson, E. Codias, A. Hernandez, M. W. Sielczak, Adam Wanner, W. M. Abraham

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

We compared the development of antigen-induced airway hyperresponsiveness (AHR) 24 h after challenge with Ascaris suum antigen in allergic sheep with acute (n = 7) and with dual (n = 7) airway responses and then attempted to modify this AHR. Cholinergic airway responsiveness was determined by measuring the carbachol dose required to increase specific lung resistance (sRL) 150% (i.e., PC150). Subsequently the sheep were challenged with antigen and sRL was measured at predetermined times to document the presence or absence of a late response. PC150 was redetermined 24 h later followed by bronchoalveolar lavage (BAL) to assess inflammation. Only dual responders developed AHR (PC150 decreased, P < 0.05). There were no significant differences in BAL between the two groups. Six dual responders were then, on separate occasions (≥3 wk), pretreated with placebo, indomethacin (2 mg/kg iv), or a leukotriene antagonist, FPL-57231 (30 mg inhaled). Neither agent significantly affected the acute response to antigen. Only FPL pretreatment blocked the late response, but both agents blocked the antigen-induced AHR 24 h later. BAL at 24 h showed no significant differences. These results indicate that only dual responders develop AHR 24 h after antigen challenge. This AHR appears independent of the late increase in sRL or the severity of pulmonary inflammation. AHR appears to be sensitive to agents that interfere with the early release or actions of cyclooxygenase and lipoxygenase metabolites in dual responders.

Original languageEnglish
Pages (from-to)864-872
Number of pages9
JournalJournal of Applied Physiology
Volume61
Issue number3
StatePublished - Dec 19 1986
Externally publishedYes

Fingerprint

Indomethacin
Sheep
Antigens
Bronchoalveolar Lavage
Ascaris suum
Leukotriene Antagonists
Lipoxygenase
Carbachol
Prostaglandin-Endoperoxide Synthases
Cholinergic Agents
FPL 57231
Pneumonia
Placebos
Inflammation
Lung

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Lanes, S., Stevenson, J. S., Codias, E., Hernandez, A., Sielczak, M. W., Wanner, A., & Abraham, W. M. (1986). Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep. Journal of Applied Physiology, 61(3), 864-872.

Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep. / Lanes, S.; Stevenson, J. S.; Codias, E.; Hernandez, A.; Sielczak, M. W.; Wanner, Adam; Abraham, W. M.

In: Journal of Applied Physiology, Vol. 61, No. 3, 19.12.1986, p. 864-872.

Research output: Contribution to journalArticle

Lanes, S, Stevenson, JS, Codias, E, Hernandez, A, Sielczak, MW, Wanner, A & Abraham, WM 1986, 'Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep', Journal of Applied Physiology, vol. 61, no. 3, pp. 864-872.
Lanes S, Stevenson JS, Codias E, Hernandez A, Sielczak MW, Wanner A et al. Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep. Journal of Applied Physiology. 1986 Dec 19;61(3):864-872.
Lanes, S. ; Stevenson, J. S. ; Codias, E. ; Hernandez, A. ; Sielczak, M. W. ; Wanner, Adam ; Abraham, W. M. / Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep. In: Journal of Applied Physiology. 1986 ; Vol. 61, No. 3. pp. 864-872.
@article{2be5d4abfa3844bcb9c39fec7799e160,
title = "Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep",
abstract = "We compared the development of antigen-induced airway hyperresponsiveness (AHR) 24 h after challenge with Ascaris suum antigen in allergic sheep with acute (n = 7) and with dual (n = 7) airway responses and then attempted to modify this AHR. Cholinergic airway responsiveness was determined by measuring the carbachol dose required to increase specific lung resistance (sRL) 150{\%} (i.e., PC150). Subsequently the sheep were challenged with antigen and sRL was measured at predetermined times to document the presence or absence of a late response. PC150 was redetermined 24 h later followed by bronchoalveolar lavage (BAL) to assess inflammation. Only dual responders developed AHR (PC150 decreased, P < 0.05). There were no significant differences in BAL between the two groups. Six dual responders were then, on separate occasions (≥3 wk), pretreated with placebo, indomethacin (2 mg/kg iv), or a leukotriene antagonist, FPL-57231 (30 mg inhaled). Neither agent significantly affected the acute response to antigen. Only FPL pretreatment blocked the late response, but both agents blocked the antigen-induced AHR 24 h later. BAL at 24 h showed no significant differences. These results indicate that only dual responders develop AHR 24 h after antigen challenge. This AHR appears independent of the late increase in sRL or the severity of pulmonary inflammation. AHR appears to be sensitive to agents that interfere with the early release or actions of cyclooxygenase and lipoxygenase metabolites in dual responders.",
author = "S. Lanes and Stevenson, {J. S.} and E. Codias and A. Hernandez and Sielczak, {M. W.} and Adam Wanner and Abraham, {W. M.}",
year = "1986",
month = "12",
day = "19",
language = "English",
volume = "61",
pages = "864--872",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep

AU - Lanes, S.

AU - Stevenson, J. S.

AU - Codias, E.

AU - Hernandez, A.

AU - Sielczak, M. W.

AU - Wanner, Adam

AU - Abraham, W. M.

PY - 1986/12/19

Y1 - 1986/12/19

N2 - We compared the development of antigen-induced airway hyperresponsiveness (AHR) 24 h after challenge with Ascaris suum antigen in allergic sheep with acute (n = 7) and with dual (n = 7) airway responses and then attempted to modify this AHR. Cholinergic airway responsiveness was determined by measuring the carbachol dose required to increase specific lung resistance (sRL) 150% (i.e., PC150). Subsequently the sheep were challenged with antigen and sRL was measured at predetermined times to document the presence or absence of a late response. PC150 was redetermined 24 h later followed by bronchoalveolar lavage (BAL) to assess inflammation. Only dual responders developed AHR (PC150 decreased, P < 0.05). There were no significant differences in BAL between the two groups. Six dual responders were then, on separate occasions (≥3 wk), pretreated with placebo, indomethacin (2 mg/kg iv), or a leukotriene antagonist, FPL-57231 (30 mg inhaled). Neither agent significantly affected the acute response to antigen. Only FPL pretreatment blocked the late response, but both agents blocked the antigen-induced AHR 24 h later. BAL at 24 h showed no significant differences. These results indicate that only dual responders develop AHR 24 h after antigen challenge. This AHR appears independent of the late increase in sRL or the severity of pulmonary inflammation. AHR appears to be sensitive to agents that interfere with the early release or actions of cyclooxygenase and lipoxygenase metabolites in dual responders.

AB - We compared the development of antigen-induced airway hyperresponsiveness (AHR) 24 h after challenge with Ascaris suum antigen in allergic sheep with acute (n = 7) and with dual (n = 7) airway responses and then attempted to modify this AHR. Cholinergic airway responsiveness was determined by measuring the carbachol dose required to increase specific lung resistance (sRL) 150% (i.e., PC150). Subsequently the sheep were challenged with antigen and sRL was measured at predetermined times to document the presence or absence of a late response. PC150 was redetermined 24 h later followed by bronchoalveolar lavage (BAL) to assess inflammation. Only dual responders developed AHR (PC150 decreased, P < 0.05). There were no significant differences in BAL between the two groups. Six dual responders were then, on separate occasions (≥3 wk), pretreated with placebo, indomethacin (2 mg/kg iv), or a leukotriene antagonist, FPL-57231 (30 mg inhaled). Neither agent significantly affected the acute response to antigen. Only FPL pretreatment blocked the late response, but both agents blocked the antigen-induced AHR 24 h later. BAL at 24 h showed no significant differences. These results indicate that only dual responders develop AHR 24 h after antigen challenge. This AHR appears independent of the late increase in sRL or the severity of pulmonary inflammation. AHR appears to be sensitive to agents that interfere with the early release or actions of cyclooxygenase and lipoxygenase metabolites in dual responders.

UR - http://www.scopus.com/inward/record.url?scp=0022448624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022448624&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 864

EP - 872

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 3

ER -